Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Young

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Applied Spectroscopy|March 3, 2020
Time-Resolved Temperature-Jump Infrared Spectroscopy at a High Repetition RateGregory M Greetham, Ian P Clark, Benjamin Young, et al.
Scientific Reports|December 5, 2019
Microbiome differences in disease-resistant vs. susceptible Acropora corals subjected to disease challenge assaysStephanie M Rosales, Margaret W Miller, Dana E Williams, et al.
Optics Express|July 21, 2023
Mask design, fabrication, and experimental ghost imaging applications for patterned X-ray illuminationAlaleh Aminzadeh, Lindon Roberts, Benjamin Young, et al.
HIV Clinical Trials|December 4, 2010
A pilot study of abacavir/lamivudine and raltegravir in antiretroviral-naïve HIV-1-infected patients: 48-week results of the SHIELD trialBenjamin Young, Thanes Vanig, Edwin Dejesus, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 30, 2006
Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohortKate Buchacz, Benjamin Young, Rose K Baker, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|June 21, 2007
Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient StudyBenjamin Young, Kate Buchacz, Rose K Baker, et al.
The Lancet. Infectious Diseases|July 1, 2015
The HIV care continuum in Latin America: challenges and opportunitiesAlicia Piñeirúa, Juan Sierra-Madero, Pedro Cahn, et al.
Antiviral Therapy|March 31, 2011
Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapyBenjamin Young, Signe Fransen, Kenneth S Greenberg, et al.
AIDS Patient Care and Stds|April 21, 2006
Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected personsBenjamin Young, Paul J Weidle, Rose K Baker, et al.
AIDS Care|August 9, 2021
Treatment challenges and health conditions among people living with HIV with or without substance use disorder in the Russian FederationSergey Kuznetsov, Anton Eremin, Elena Zaytseva, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Applied Spectroscopy|March 3, 2020
Time-Resolved Temperature-Jump Infrared Spectroscopy at a High Repetition RateGregory M Greetham, Ian P Clark, Benjamin Young, et al.
Scientific Reports|December 5, 2019
Microbiome differences in disease-resistant vs. susceptible Acropora corals subjected to disease challenge assaysStephanie M Rosales, Margaret W Miller, Dana E Williams, et al.
Optics Express|July 21, 2023
Mask design, fabrication, and experimental ghost imaging applications for patterned X-ray illuminationAlaleh Aminzadeh, Lindon Roberts, Benjamin Young, et al.
HIV Clinical Trials|December 4, 2010
A pilot study of abacavir/lamivudine and raltegravir in antiretroviral-naïve HIV-1-infected patients: 48-week results of the SHIELD trialBenjamin Young, Thanes Vanig, Edwin Dejesus, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 30, 2006
Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohortKate Buchacz, Benjamin Young, Rose K Baker, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|June 21, 2007
Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient StudyBenjamin Young, Kate Buchacz, Rose K Baker, et al.
The Lancet. Infectious Diseases|July 1, 2015
The HIV care continuum in Latin America: challenges and opportunitiesAlicia Piñeirúa, Juan Sierra-Madero, Pedro Cahn, et al.
Antiviral Therapy|March 31, 2011
Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapyBenjamin Young, Signe Fransen, Kenneth S Greenberg, et al.
AIDS Patient Care and Stds|April 21, 2006
Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected personsBenjamin Young, Paul J Weidle, Rose K Baker, et al.
AIDS Care|August 9, 2021
Treatment challenges and health conditions among people living with HIV with or without substance use disorder in the Russian FederationSergey Kuznetsov, Anton Eremin, Elena Zaytseva, et al.
Pageof 11